| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/24/2008 | US20080020406 Antibodies to a human Kchannel and therapeutic applications thereof |
| 01/24/2008 | US20080020372 Methods for Detecting and Treating Cancer |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080020062 Nutritional composition for the treatment of pressure ulcers |
| 01/24/2008 | US20080020045 Combination Degradable and Non-Degradable Matrices for Active Agent Delivery |
| 01/24/2008 | US20080020036 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 01/24/2008 | US20080020031 Methods and compositions for altering mucus secretion |
| 01/24/2008 | US20080020024 Fast dissolving orally consumable films |
| 01/24/2008 | US20080020018 Combination Products |
| 01/24/2008 | US20080020017 Intraocular Irrigating Solution Having Improved Flow Characteristics |
| 01/24/2008 | US20080020016 Pharmaceutical compositions for sustained release delivery of peptides |
| 01/24/2008 | US20080020000 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 01/24/2008 | US20080019994 Immunization Against Chlamydia Infection |
| 01/24/2008 | US20080019987 using a composition comprising a multimeric galectin-1 polypeptide to decrease inflammation of a tissue |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019981 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 01/24/2008 | US20080019980 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 01/24/2008 | US20080019978 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases |
| 01/24/2008 | US20080019975 Novel Regimens for Treating Diseases and Disorders |
| 01/24/2008 | US20080019971 36P6D5: secreted tumor antigen |
| 01/24/2008 | US20080019967 Inflammatory mediator antagonists |
| 01/24/2008 | US20080019964 Use of certain drugs for treating nerve root injury |
| 01/24/2008 | US20080019960 Use of alefacept aka AMVIVE (reg) to treat herpes, HIV, hepatitis, papillomavirus, Epstein-Barr virus, cytomegalovirus in humans; includes co-infected individuals |
| 01/24/2008 | US20080019959 Process for separating and determining the viral load in a pancreatin sample |
| 01/24/2008 | US20080019958 Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (mgat3), and uses thereof |
| 01/24/2008 | US20080019957 Topically applied probucol-containing agent with protective and regenerative effect |
| 01/24/2008 | US20080019956 Enzymatic prevention and control of biofilm |
| 01/24/2008 | US20080019955 Surface Protection of Exposed Biological Tissues |
| 01/24/2008 | US20080019943 Broad spectrum immune and antiviral gene modulation by oral interferon |
| 01/24/2008 | US20080019942 Novel inhibitors of hepatitis c virus replication |
| 01/24/2008 | US20080019941 Methods, systems and reagents for scar reduction |
| 01/24/2008 | US20080019940 Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| 01/24/2008 | US20080019918 Medicinal Preparation |
| 01/24/2008 | US20080019916 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 01/24/2008 | US20080019913 Enkepahlin analogs with improved bioavailability |
| 01/24/2008 | US20080019912 Glycoprotein 5 (GP5) and M protein of PRRSV linked by a disulfide bond gives rise to protective antigenic determinant (PAD polypeptide) that is used provide protection PRRSV; immunizing pigs |
| 01/24/2008 | US20080019911 Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4 |
| 01/24/2008 | US20080019910 Cancer Treatment and Cancer Treatment Efficacy Prediction by Blocking and Detecting Protease Inhibitors |
| 01/24/2008 | US20080019908 Novel amphiphilic substance, and drug delivery system and molecular imaging system using the same |
| 01/24/2008 | DE19726167B4 Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung Insulin, to processes for its preparation and pharmaceutical preparation containing |
| 01/24/2008 | DE10121982B4 Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung Nanoparticles of protein with coupled apolipoprotein E to cross the blood-brain barrier and method for their preparation |
| 01/24/2008 | CA2829865A1 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 01/24/2008 | CA2658582A1 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 01/24/2008 | CA2658393A1 Human endogenous retrovirus polypeptide compositions and methods of use thereof |
| 01/24/2008 | CA2658352A1 Treatment for intimal hyperplasia and related conditions |
| 01/24/2008 | CA2658274A1 Use of soluble cd160 to suppress immunity |
| 01/24/2008 | CA2658267A1 Sdf-1 binding nucleic acids |
| 01/24/2008 | CA2658082A1 Physiologically active polypeptide- or protein-encapsulating polymer micelles, and method for production of the same |
| 01/24/2008 | CA2657532A1 Methods for treating pain and screening analgesic compounds |
| 01/24/2008 | CA2657349A1 Human growth and differentiation factor gdf-5 |
| 01/24/2008 | CA2657269A1 New indications for direct thrombin inhibitors |
| 01/24/2008 | CA2657266A1 New indications for direct thrombin inhibitors in the cardiovascular field |
| 01/24/2008 | CA2656883A1 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 01/24/2008 | CA2652718A1 Recombinant host for producing l-asparaginase ii |
| 01/24/2008 | CA2630857A1 Fsh mutants |
| 01/23/2008 | EP1881327A2 Diagnosis and treatment of malignant neoplasms |
| 01/23/2008 | EP1881075A1 Retroviral vectors having a reduced recombination rate |
| 01/23/2008 | EP1881070A2 Human cytokine as ligand of the zalpha receptor and uses thereof |
| 01/23/2008 | EP1881065A1 DINO polypetide |
| 01/23/2008 | EP1881020A1 Polymeric derivative of cytidine metabolic antagonist |
| 01/23/2008 | EP1881007A1 LLR-J24 related proteins |
| 01/23/2008 | EP1881006A1 Parathyroid hormone analogues for the treatment of osteoporosis |
| 01/23/2008 | EP1881002A1 HCV NS-3 serine protease inhibitors |
| 01/23/2008 | EP1881001A1 HCV NS-3 serine protease inhibitors |
| 01/23/2008 | EP1880743A1 Microneedle for delivering a substance into the dermis |
| 01/23/2008 | EP1880737A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
| 01/23/2008 | EP1880733A1 Method for increasing longevity of a human being and animals |
| 01/23/2008 | EP1880732A1 Parathyroid hormone formulation |
| 01/23/2008 | EP1880731A1 Human growth and differentiation factor GDF-5 |
| 01/23/2008 | EP1880730A1 Functions and uses of gpr39 gene in mammalian central nervous system |
| 01/23/2008 | EP1880729A1 Use of soluble CD160 to suppress immunity |
| 01/23/2008 | EP1880728A1 Peptide having anti-anxiety effect and method for screening thereof |
| 01/23/2008 | EP1879919A2 Polypeptide, vaccine and use thereof |
| 01/23/2008 | EP1879917A2 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same |
| 01/23/2008 | EP1879911A1 Dye conjugates of template-fixed peptidomimetics |
| 01/23/2008 | EP1879650A1 Rate control during af using cellular intervention to modulate av node |
| 01/23/2008 | EP1879626A2 Amphiphilic polymers and methods of use thereof |
| 01/23/2008 | EP1879618A2 A method for modulating hla class ii tumor cell surface expression with a cytokine mixture |
| 01/23/2008 | EP1879615A2 Methods for the rapid expansion of antigen specific t-cells |
| 01/23/2008 | EP1879612A2 Use of native peptides and their optimized derivatives for vaccination |
| 01/23/2008 | EP1879611A2 Insp163 polypeptides for the treatment or prevention of cancer and arthritis |
| 01/23/2008 | EP1879610A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases |
| 01/23/2008 | EP1879609A2 Use of histones for therapeutic purposes |
| 01/23/2008 | EP1879608A1 Method for fostering bone formation and preservation |
| 01/23/2008 | EP1879607A2 Hcv ns3 protease inhibitors |
| 01/23/2008 | EP1879606A1 Compositions and methods for promoting hemostasis and other physiological activities |
| 01/23/2008 | EP1879605A2 Novel nutraceutical compositions |
| 01/23/2008 | EP1879604A2 Pif tetrapeptides |
| 01/23/2008 | EP1879572A2 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| 01/23/2008 | EP1879465A1 Composition comprising peptide |
| 01/23/2008 | EP1879448A2 Compositions and methods related to serpin spi6 |
| 01/23/2008 | EP1773377A4 Food ingredients and food products treated with an oxidoreductase and methods for preparing such food ingredients and food products |
| 01/23/2008 | EP1622635A4 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 01/23/2008 | EP1620554B1 Recombinant fel d 1 allergen |
| 01/23/2008 | EP1601772B1 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
| 01/23/2008 | EP1572679A4 Crfr1 selective ligands |
| 01/23/2008 | EP1446478B1 Dimerized growth factor and materials and methods for producing it |
| 01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |